Bioatlainc Stock Buy Hold or Sell Recommendation
| BCAB Stock | USD 2.43 0.10 3.95% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding BioatlaInc is 'Strong Sell'. Macroaxis provides BioatlaInc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BCAB positions. The advice algorithm takes into account all of BioatlaInc's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting BioatlaInc's buy or sell advice are summarized below:
Real Value 5.27 | Target Price 14 | Hype Value 2.34 | Market Value 2.43 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell BioatlaInc given historical horizon and risk tolerance towards BioatlaInc. When Macroaxis issues a 'buy' or 'sell' recommendation for BioatlaInc, the advice is generated through an automated system that utilizes algorithms and statistical models.
BioatlaInc |
Execute BioatlaInc Buy or Sell Advice
The BioatlaInc recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioatlaInc. Macroaxis does not own or have any residual interests in BioatlaInc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioatlaInc's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
BioatlaInc Trading Alerts and Improvement Suggestions
| BioatlaInc is way too risky over 90 days horizon | |
| BioatlaInc appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (123.46 M) with loss before overhead, payroll, taxes, and interest of (79.35 M). | |
| BioatlaInc currently holds about 178.12 M in cash with (104.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 64.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: BioAtla, Inc. Sees Large Growth in Short Interest - Defense World |
BioatlaInc Returns Distribution Density
The distribution of BioatlaInc's historical returns is an attempt to chart the uncertainty of BioatlaInc's future price movements. The chart of the probability distribution of BioatlaInc daily returns describes the distribution of returns around its average expected value. We use BioatlaInc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioatlaInc returns is essential to provide solid investment advice for BioatlaInc.
| Mean Return | 0.37 | Value At Risk | -8.96 | Potential Upside | 14.88 | Standard Deviation | 7.33 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioatlaInc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioatlaInc Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as BioatlaInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioatlaInc backward and forwards among themselves. BioatlaInc's institutional investor refers to the entity that pools money to purchase BioatlaInc's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Vontobel Holding Ltd. | 2023-12-31 | 706.1 K | Boxer Capital Llc | 2023-12-31 | 686.3 K | Adage Capital Partners Gp Llc | 2023-12-31 | 600 K | Massachusetts Financial Services Company | 2023-12-31 | 529.2 K | Healthcare Of Ontario Pension Plan Trust Fund | 2023-12-31 | 512.3 K | Norges Bank | 2023-12-31 | 488.2 K | Northern Trust Corp | 2023-12-31 | 355.9 K | Bank Of Montreal | 2023-12-31 | 300.6 K | Bmo Capital Markets Corp. | 2023-12-31 | 300.6 K | Soleus Capital Management, L.p. | 2023-12-31 | 4.1 M | Tang Capital Management Llc | 2023-09-30 | 3.8 M |
BioatlaInc Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (1.5M) | (590K) | (924K) | (265K) | (121K) | (127.1K) | |
| Change In Cash | (7.2M) | 234.9M | 6.4M | (29.5M) | (104.0M) | (98.8M) | |
| Free Cash Flow | (11.2M) | (36.9M) | (63.1M) | (90.7M) | (104.1M) | (98.9M) | |
| Depreciation | 860K | 1.0M | 1.3M | 1.2M | 1.2M | 1.2M | |
| Other Non Cash Items | (5.8M) | (6.5M) | 3K | 13K | 5.3M | 5.6M | |
| Capital Expenditures | 1.5M | 590K | 924K | 268K | 98K | 93.1K | |
| Net Income | (29.9M) | (35.9M) | (95.4M) | (106.5M) | (123.5M) | (117.3M) | |
| End Period Cash Flow | 3.7M | 238.6M | 245.0M | 215.5M | 111.5M | 151.3M | |
| Change To Netincome | (5.8M) | 1.0M | 24.4M | 14.6M | 16.8M | 17.6M |
BioatlaInc Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioatlaInc or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioatlaInc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioatlaInc stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.18 | |
β | Beta against NYSE Composite | 3.16 | |
σ | Overall volatility | 7.43 | |
Ir | Information ratio | 0.04 |
BioatlaInc Volatility Alert
BioatlaInc is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioatlaInc's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioatlaInc's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BioatlaInc Fundamentals Vs Peers
Comparing BioatlaInc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioatlaInc's direct or indirect competition across all of the common fundamentals between BioatlaInc and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioatlaInc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioatlaInc's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioatlaInc by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioatlaInc to competition |
| Fundamentals | BioatlaInc | Peer Average |
| Return On Equity | -0.98 | -0.31 |
| Return On Asset | -0.47 | -0.14 |
| Current Valuation | 12.67 M | 16.62 B |
| Shares Outstanding | 48.1 M | 571.82 M |
| Shares Owned By Insiders | 9.68 % | 10.09 % |
| Shares Owned By Institutions | 64.48 % | 39.21 % |
| Number Of Shares Shorted | 5.59 M | 4.71 M |
| Price To Book | 2.13 X | 9.51 X |
| Price To Sales | 989.22 X | 11.42 X |
| Gross Profit | (79.35 M) | 27.38 B |
| EBITDA | (128.47 M) | 3.9 B |
| Net Income | (123.46 M) | 570.98 M |
| Cash And Equivalents | 178.12 M | 2.7 B |
| Cash Per Share | 4.77 X | 5.01 X |
| Total Debt | 2.46 M | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 7.48 X | 2.16 X |
| Book Value Per Share | 1.47 X | 1.93 K |
| Cash Flow From Operations | (104.02 M) | 971.22 M |
| Short Ratio | 11.56 X | 4.00 X |
| Earnings Per Share | (2.58) X | 3.12 X |
| Target Price | 11.5 | |
| Number Of Employees | 65 | 18.84 K |
| Beta | 1.06 | -0.15 |
| Market Capitalization | 121.68 M | 19.03 B |
| Total Asset | 119.66 M | 29.47 B |
| Retained Earnings | (416.26 M) | 9.33 B |
| Working Capital | 88.06 M | 1.48 B |
| Net Asset | 119.66 M |
Note: Disposition of 572 shares by Sievers Eric of BioatlaInc at 3.44 subject to Rule 16b-3 [view details]
BioatlaInc Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioatlaInc . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioatlaInc Buy or Sell Advice
When is the right time to buy or sell BioatlaInc? Buying financial instruments such as BioatlaInc Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 5.4M | 4.0M | 2.5M | 2.3M | Total Assets | 254.4M | 225.7M | 119.7M | 159.6M |
Use Investing Ideas to Build Portfolios
In addition to having BioatlaInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rubber and Plastic Products Thematic Idea Now
Rubber and Plastic Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out BioatlaInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.Note that the BioatlaInc information on this page should be used as a complementary analysis to other BioatlaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for BioatlaInc Stock analysis
When running BioatlaInc's price analysis, check to measure BioatlaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioatlaInc is operating at the current time. Most of BioatlaInc's value examination focuses on studying past and present price action to predict the probability of BioatlaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioatlaInc's price. Additionally, you may evaluate how the addition of BioatlaInc to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is BioatlaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioatlaInc. If investors know BioatlaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioatlaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.58) | Quarterly Revenue Growth 0.316 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of BioatlaInc is measured differently than its book value, which is the value of BioatlaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BioatlaInc's value that differs from its market value or its book value, called intrinsic value, which is BioatlaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioatlaInc's market value can be influenced by many factors that don't directly affect BioatlaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioatlaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioatlaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioatlaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.